Literature DB >> 7775441

Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion.

A H Merrill1, S Lingrell, E Wang, M Nikolova-Karakashian, T R Vales, D E Vance.   

Abstract

Sphingolipids are constituents of liver and lipoproteins, but relatively little is known about their synthesis and secretion. Incubation of rat hepatocytes with [14C]- or [3H]serine labeled the long-chain base backbones of mainly ceramide and sphingomyelin. Most of the labeled sphingolipids were associated with the cells; however, 1-5% (the majority of which was ceramide) was released into the medium as part of very low density lipoproteins (VLDL). Since this is the first report that lipoproteins contain ceramide, lipoproteins were isolated from rat plasma, and the ceramide contents were (per mg of protein): 6.5 nmol for VLDL (d < 1.018), 0.6 nmol for low density lipoproteins (1.018 < d < 1.063), 0.2 nmol for high density lipoproteins (1.063 < d < 1.18), and 0.1 nmol for the albumin fraction; the lipoproteins also contained 0.1-0.4 nmol of free sphingosine/mg of protein. A number of factors affected the secretion of radiolabeled sphingolipids: 1) addition of palmitic acid, but not stearic or oleic acid, enhanced secretion due to an increase in long-chain base synthesis de novo. 2) Choline deficiency caused a 42% reduction in the secretion of radiolabeled sphingomyelin, but this was due to an effect on VLDL secretion rather than a decrease in sphingolipid synthesis. Removal of choline was examined because previous studies (Yao, Z. M., and Vance, D. E. (1988) J. Biol. Chem. 263, 2998-3004) have shown that choline deficiencies depress phosphatidylcholine synthesis and lipoprotein secretion. 3) Incubation of the cells with fumonisin B1, a mycotoxin inhibitor of sphinganine (sphingosine) N-acyltransferase, reduced overall sphingolipid synthesis and secretion by 90%, but had no effect on the secretion of apoB, phosphatidylcholine, or cholesterol. All together, these findings demonstrate that rat hepatocytes synthesize ceramide and sphingomyelin de novo and incorporate them into both cellular membranes and secreted VLDL, but normal sphingolipid synthesis is not required for lipoprotein secretion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775441     DOI: 10.1074/jbc.270.23.13834

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Novel Interconnections in Lipid Metabolism Revealed by Overexpression of Sphingomyelin Synthase-1.

Authors:  Gergana M Deevska; Patrick P Dotson; Alexander A Karakashian; Giorgis Isaac; Mark Wrona; Samuel B Kelly; Alfred H Merrill; Mariana N Nikolova-Karakashian
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

3.  Sphingoid bases of dietary ceramide 2-aminoethylphosphonate, a marine sphingolipid, absorb into lymph in rats.

Authors:  Nami Tomonaga; Tsuyoshi Tsuduki; Yuki Manabe; Tatsuya Sugawara
Journal:  J Lipid Res       Date:  2018-12-14       Impact factor: 5.922

4.  Intestinal absorption of dietary maize glucosylceramide in lymphatic duct cannulated rats.

Authors:  Tatsuya Sugawara; Tsuyoshi Tsuduki; Saeko Yano; Mayumi Hirose; Jingjing Duan; Kazuhiko Aida; Ikuo Ikeda; Takashi Hirata
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

5.  Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss.

Authors:  B D Kayser; M Lhomme; M C Dao; F Ichou; J-L Bouillot; E Prifti; A Kontush; J-M Chevallier; J Aron-Wisnewsky; I Dugail; K Clément
Journal:  Int J Obes (Lond)       Date:  2017-03-10       Impact factor: 5.095

6.  Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice.

Authors:  Gergana M Deevska; Krassimira A Rozenova; Natalia V Giltiay; Melissa A Chambers; James White; Boris B Boyanovsky; Jia Wei; Alan Daugherty; Eric J Smart; Michael B Reid; Alfred H Merrill; Mariana Nikolova-Karakashian
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

7.  Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice.

Authors:  Carmen García-Ruiz; Anna Colell; Montserrat Marí; Albert Morales; María Calvo; Carlos Enrich; José C Fernández-Checa
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 8.  Defect of insulin signal in peripheral tissues: Important role of ceramide.

Authors:  Rima Hage Hassan; Olivier Bourron; Eric Hajduch
Journal:  World J Diabetes       Date:  2014-06-15

9.  Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations.

Authors:  A Kotronen; V R Velagapudi; L Yetukuri; J Westerbacka; R Bergholm; K Ekroos; J Makkonen; M-R Taskinen; M Oresic; H Yki-Järvinen
Journal:  Diabetologia       Date:  2009-02-13       Impact factor: 10.122

10.  Cholesterol regulates oxysterol binding protein (OSBP) phosphorylation and Golgi localization in Chinese hamster ovary cells: correlation with stimulation of sphingomyelin synthesis by 25-hydroxycholesterol.

Authors:  M K Storey; D M Byers; H W Cook; N D Ridgway
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.